- Home
- KGEI vs STIM Comparison
KGEI vs STIM Comparison
Compare KGEI & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KGEI
- STIM
- Stock Information
- Founded
- KGEI 2008
- STIM 2003
- Country
- KGEI United States
- STIM United States
- Employees
- KGEI N/A
- STIM N/A
- Industry
- KGEI
- STIM Medical/Dental Instruments
- Sector
- KGEI
- STIM Health Care
- Exchange
- KGEI Nasdaq
- STIM Nasdaq
- Market Cap
- KGEI 254.9M
- STIM 224.8M
- IPO Year
- KGEI N/A
- STIM 2018
- Fundamental
- Price
- KGEI $5.56
- STIM $2.90
- Analyst Decision
- KGEI Strong Buy
- STIM Strong Buy
- Analyst Count
- KGEI 1
- STIM 2
- Target Price
- KGEI $11.00
- STIM $7.00
- AVG Volume (30 Days)
- KGEI 123.4K
- STIM 1.2M
- Earning Date
- KGEI 11-11-2025
- STIM 11-11-2025
- Dividend Yield
- KGEI N/A
- STIM N/A
- EPS Growth
- KGEI 35.27
- STIM N/A
- EPS
- KGEI 0.54
- STIM N/A
- Revenue
- KGEI $57,936,000.00
- STIM $111,106,000.00
- Revenue This Year
- KGEI $14.07
- STIM $105.70
- Revenue Next Year
- KGEI $26.69
- STIM $11.77
- P/E Ratio
- KGEI $10.28
- STIM N/A
- Revenue Growth
- KGEI 6.52
- STIM 54.17
- 52 Week Low
- KGEI $2.91
- STIM $0.52
- 52 Week High
- KGEI $9.89
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- KGEI 47.89
- STIM 47.33
- Support Level
- KGEI $5.15
- STIM $2.58
- Resistance Level
- KGEI $5.73
- STIM $3.01
- Average True Range (ATR)
- KGEI 0.23
- STIM 0.18
- MACD
- KGEI -0.00
- STIM 0.04
- Stochastic Oscillator
- KGEI 54.91
- STIM 78.16
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.